A randomized double-blinded clinical trial to investigate the role of ultrasound-guided transversus abdominis plane block
- Conditions
- CancerSurgeryAnaesthesia
- Registration Number
- PACTR202303539794048
- Lead Sponsor
- Bahir Dar University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Female
- Target Recruitment
- 60
All adults aged greater than 18 years old with the following criteria will be considered.
•Patients with the classification of ASA physical status II and III
•Patients who can tolerate a general anesthetic
• Patients undergoing cervical cancer surgery (radical hysterectomy) under general anesthesia,
•Patients who can provide informed consent for the surgery
•20 ml of 0.25 % bupivacaine will be given for cases (TAP block) at the end of the surgery
•Patients' weights are between 40-80 kg.
•Patients who can provide informed consent for the surgery
•Patients who have bleeding disorders
•Patients who are GCS <15
•Communication failure
•Patients who have an allergy to local anesthetics
•Patients who have multiple site surgery (outside of abdomen)
•Patients who have underlying cardiovascular diseases
•Patients with chronic pain and opioid use (using oral morphine greater than 100 mg daily).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is postoperative pain which a numerical rating scale will assess
- Secondary Outcome Measures
Name Time Method Total postoperative analgesic consumption: the total amount of analgesic requirement within the given postoperative period <br>Time for first-time analgesic request: the initial time in which the patient feels pain and asks for analgesia<br> Complications: any adverse events reported after surgery